Evaluation of the Qiagen Artus C. Difficile QS-RGQ Kit for Detection of Clostridium Difficile Toxins A and B in Clinical Stool Specimens
Overview
Affiliations
We compared the Qiagen artus C. difficile QS-RGQ kit, a new nucleic acid amplification test for the detection of Clostridium difficile toxins in stool specimens, with the Cepheid Xpert C. difficile test. The sensitivity, specificity, positive predictive value, and negative predictive value for the Qiagen artus C. difficile QS-RGQ test were 100%, 89.5%, 60.9%, and 100%, and those for the Cepheid Xpert C. difficile test were 100%, 90%, 62.2%, and 100%, respectively.
Overview of current detection methods and microRNA potential in infection screening.
Bocchetti M, Ferraro M, Melisi F, Grisolia P, Scrima M, Cossu A World J Gastroenterol. 2023; 29(22):3385-3399.
PMID: 37389232 PMC: 10303512. DOI: 10.3748/wjg.v29.i22.3385.
Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis.
Bai Y, Hao Y, Song Z, Chu W, Jin Y, Wang Y Braz J Microbiol. 2021; 52(4):1937-1949.
PMID: 34455573 PMC: 8578272. DOI: 10.1007/s42770-021-00563-7.
Laboratory Diagnostic Methods for Infection: the First Systematic Review and Meta-analysis in Korea.
Chung H, Park J, Shin B Ann Lab Med. 2020; 41(2):171-180.
PMID: 33063678 PMC: 7591293. DOI: 10.3343/alm.2021.41.2.171.
Laboratory Tests for the Diagnosis of .
Carroll K, Mizusawa M Clin Colon Rectal Surg. 2020; 33(2):73-81.
PMID: 32104159 PMC: 7042017. DOI: 10.1055/s-0039-3400476.
Kraft C, Parrott J, Cornish N, Rubinstein M, Weissfeld A, McNult P Clin Microbiol Rev. 2019; 32(3).
PMID: 31142497 PMC: 6589859. DOI: 10.1128/CMR.00032-18.